Skip to research

COMPANY RESEARCH / 2498.TW

HTC

VIVE Eagle AI glasses

Where it fits in smart glasses

VIVE Eagle camera/audio AI glasses (Zeiss lenses, Gemini and OpenAI GPT assistants, from 48.5 g), on sale in Taiwan since Sept 1, 2025 at NT$15,600; VIVE XR headsets.

What the evidence establishes

Smart-glasses evidence

Disclosed: HTC’s product page describes VIVE Eagle, and its newsroom gives the NT$15,600 price and the Sept 1, 2025 on-sale date.

An explicit smart-glasses product, design-in, supply role, program, application page or partnership, including wrist or ring input sold with glasses. For a device maker, it means the company’s own glasses, not a supplier relationship. This does not establish revenue, market share, volumes or future sourcing.

Listed as a device maker for its own glasses, not as a supplier of the parts inside.

Component roleVIVE Eagle AI glasses
EvidenceDisclosed: HTC’s product page describes VIVE Eagle, and its newsroom gives the NT$15,600 price and the Sept 1, 2025 on-sale date.
How we knowDisclosed The company’s own filing, release, annual report, product page or investor record describes the smart-glasses role. Where customers are unnamed, the listing says so.
Primary sourceHTC — supporting disclosure
Company or official disclosure; vendor claims are attributed to their source.
Checked. This is the research review date, not the source publication or quote time.

Keep in perspective

Sold in Taiwan. HTC’s 2025 deal with Google was a non-exclusive XR IP license and staff transfer, not a sale of the business.

Specialist business exposure. This describes the breadth or role of the business; it is not an investment rating. A smart-glasses product, design-in or partnership does not by itself establish material glasses revenue, market share, or future returns.

Connections to the assembly

This company is mapped at sector level. The reviewed evidence does not establish a direct match to a specific illustrated part. Explore device makers & platforms for the broader relationship.

Related research

Companies with overlapping sector exposure. Their products and evidence may differ; this is not a list of equivalent investments.

Suggest a correction · Research and market-data disclosures